Intraductal Carcinoma of the Prostate versus Simulants: A Differential Diagnosis Growing in Clinical Impact.

Cancers (Basel) · 2024 · PMC10968618 · PMID 38539432

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

The stakes of this differential diagnosis are quite significant, especially in the biopsy setting, given the marked differences in the management of urothelial carcinoma versus prostatic adenocarcinoma [ 93 ].

also in 5,705 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.